Insider trading

Period: 120 months Stock: NTRA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

951 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

951 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

951 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

951 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
951 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
951 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

951 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
22 Apr 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$132.09K 911 at 145.00
1.2%
Planned (10b5-1)
21 Apr 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 2×
$242.19K 1,664 at 145.55
0.8%
Planned (10b5-1)
21 Apr 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$88.78K 610 at 145.55
0.8%
Planned (10b5-1)
21 Apr 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 2×
$68.41K 470 at 145.55
0.2%
Planned (10b5-1)
21 Apr 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$49.92K 343 at 145.55
0.2%
Planned (10b5-1)
21 Apr 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 2×
$43.09K 296 at 145.56
0.2%
Planned (10b5-1)
21 Apr 2025
Sheena Jonathan Director
Sold on a plan 2×
$12.52K 86 at 145.55
0.0%
Planned (10b5-1)
4 Apr 2025
Sheena Jonathan Director
Sold on a plan 5×
$408.75K 3,070 at 133.14
1.2%
Planned (10b5-1)
3 Apr 2025
Sheena Jonathan Director · indirect
Sold on a plan 9×
$417.58K 3,000 at 139.19
6.9%
Planned (10b5-1)
1 Apr 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 4×
$2.23M 15,898 at 140.48
7.5%
Planned (10b5-1)
1 Apr 2025
Sold on a plan 5×
$563.10K 4,000 at 140.78
29.2%
Planned (10b5-1)
1 Apr 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$421.43K 3,000 at 140.48
2.1%
Planned (10b5-1)
31 Mar 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 2×
$1.32M 9,563 at 138.41
4.3%
Planned (10b5-1)
31 Mar 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$354.60K 2,562 at 138.41
3.3%
Planned (10b5-1)
31 Mar 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 2×
$194.33K 1,404 at 138.41
0.6%
Planned (10b5-1)
18 Mar 2025
Sheena Jonathan Director · indirect
Sold on a plan 4×
$436.95K 3,000 at 145.65
6.7%
Planned (10b5-1)
18 Mar 2025
Sheena Jonathan Director
Sold on a plan 3×
$393.03K 2,700 at 145.57
1.0%
Planned (10b5-1)
17 Mar 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$978.68K 6,702 at 146.03
3.2%
Planned (10b5-1)
17 Mar 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 2×
$164.58K 1,127 at 146.04
0.0%
Planned (10b5-1)
17 Mar 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 2×
$149.84K 1,026 at 146.04
0.7%
Planned (10b5-1)
17 Mar 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 2×
$135.52K 928 at 146.04
0.4%
Planned (10b5-1)
17 Mar 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$116.10K 795 at 146.04
0.5%
Planned (10b5-1)
17 Mar 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$115.66K 792 at 146.04
1.1%
Planned (10b5-1)
17 Mar 2025
Sheena Jonathan Director
Sold on a plan
$26.43K 181 at 146.03
0.1%
Planned (10b5-1)
14 Mar 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold at will 5×
$7.39M 50,000 at 147.70
2.1%
Not planned
12 Mar 2025
Sold on a plan 4×
$590.77K 4,000 at 147.69
29.2%
Planned (10b5-1)
5 Mar 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 5×
$12.52M 87,272 at 143.40
30.0%
Planned (10b5-1)
5 Mar 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 4×
$859.73K 6,000 at 143.29
4.0%
Planned (10b5-1)
26 Feb 2025
Sheena Jonathan Director · indirect
Sold on a plan 10×
$481.42K 3,000 at 160.47
6.5%
Planned (10b5-1)
26 Feb 2025
Sheena Jonathan Director
Sold on a plan 5×
$433.45K 2,700 at 160.54
1.0%
Planned (10b5-1)
6 Feb 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$290.12K 1,632 at 177.77
1.1%
Planned (10b5-1)
6 Feb 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$117.86K 663 at 177.77
0.4%
Planned (10b5-1)
3 Feb 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 4×
$7.69M 43,502 at 176.88
38.1%
Planned (10b5-1)
31 Jan 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$402.29K 2,286 at 175.98
2.2%
Planned (10b5-1)
31 Jan 2025
Sheena Jonathan Director
Sold on a plan
$28.79K 163 at 176.60
0.1%
Planned (10b5-1)
29 Jan 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 4×
$2.27M 13,685 at 165.87
5.1%
Planned (10b5-1)
29 Jan 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 2×
$995.72K 6,003 at 165.87
0.3%
Planned (10b5-1)
29 Jan 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$862.69K 5,201 at 165.87
3.7%
Planned (10b5-1)
29 Jan 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 3×
$791.69K 4,773 at 165.87
2.2%
Planned (10b5-1)
29 Jan 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 4×
$719.04K 4,335 at 165.87
4.0%
Planned (10b5-1)
29 Jan 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 3×
$668.45K 4,030 at 165.87
2.7%
Planned (10b5-1)
29 Jan 2025
Sheena Jonathan Director
Sold on a plan 2×
$174.83K 1,054 at 165.87
0.4%
Planned (10b5-1)
27 Jan 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$233.42K 1,442 at 161.87
1.3%
Planned (10b5-1)
24 Jan 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$162.69K 946 at 171.98
0.9%
Planned (10b5-1)
23 Jan 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$84.69K 495 at 171.09
0.4%
Planned (10b5-1)
22 Jan 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 2×
$12.96M 78,553 at 164.97
22.7%
Planned (10b5-1)
22 Jan 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$4.28M 25,931 at 164.97
19.1%
Planned (10b5-1)
22 Jan 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 2×
$4.10M 24,861 at 164.97
15.0%
Planned (10b5-1)
22 Jan 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 2×
$3.64M 22,039 at 164.97
9.2%
Planned (10b5-1)
22 Jan 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$3.50M 21,228 at 164.97
12.6%
Planned (10b5-1)
Showing 251–300 of 951. ← Newer Page 6 of 20 Older →